Signaling Pathways - constitutive androstane receptor (CAR) - dopamine receptor - c-MET - DREADD Ligands
清除全部
-
B5832 Altiratinib1 CitationTarget: FLT3|VEGFR|Trk Receptors|c-MET|Tie-2Summary: c-MET/TIE-2/VEGFR抑制剂 -
B7468 CITCO1 CitationTarget: constitutive androstane receptor (CAR)Summary: 组成型雄激素受体（CAR）激动剂 -
B6506 SCH 23390 hydrochlorideTarget: dopamine receptor|5-HT1 Receptor|5-HT2 ReceptorSummary: 多巴胺受体拮抗剂 -
A8448 INCB28060中文名: 苯扎米特Target: c-METSummary: C-Met抑制剂 -
A5057 MGCD-265Target: VEGFR|c-METSummary: Met/Flt/Flk/Ron/Tie-2抑制剂 -
A2412 CP-724714Target: VEGFR|PDGFR|Bcr-Abl|Src|EGFR|c-MET|Insulin Receptors|IRG-1RSummary: 有效的HER2选择性抑制剂 -
A5096 PF-04217903Target: c-METSummary: C-Met的选择性和ATP竞争性抑制剂 -
A2307 PHA-6657521 CitationTarget: c-METSummary: c-Met的ATP竞争性、有效的、选择性抑制剂 -
A3712 PF-04217903 methanesulfonateTarget: c-METSummary: c-Met抑制剂 -
A3317 Clozapine N-oxide(CNO)1 Citation中文名: 氯氮平的N-氧化物Target: DREADD LigandsSummary: Clozapine代谢产物，用于化学遗传学